For Investors

Press Releases

Press Releases

This section and the included press releases are presented for historical purposes only. Press releases and other documents speak only as of the date thereof.

Date	Title
August 14, 2019	Novan Advances Women’s Health Business Unit with Non-Dilutive Funding
August 13, 2019	Novan Takes Steps to Reduce Real Estate Footprint
August 13, 2019	Novan’s Phase 3 Molluscum Pivotal Program Completes Enrollment
July 24, 2019	Novan’s Drug Substance Demonstrates Inhibition of HPV-18 Virus Production
July 11, 2019	Novan SB206 Phase 3 Molluscum Pivotal Program Update
June 19, 2019	Novan Expands External Business Partner Network
June 13, 2019	Novan to Participate in JMP Securities Life Sciences Conference
June 6, 2019	Novan Achieves Compliance with Nasdaq Listing Rule 5450(b)(2)(A)
June 4, 2019	First Patient Enrolled and Dosed in Novan’s SB206 Phase 3 Molluscum Program
May 31, 2019	Novan Announces 2019 Annual Meeting of Stockholders for July 31, 2019
May 7, 2019	Novan to Present Clinical Data at Annual Meeting of the Society for Investigative Dermatology
May 6, 2019	Novan Completes Funding Transaction with Ligand Pharmaceuticals
May 1, 2019	Novan Confirms Corporate Update Conference Call and Webcast
April 29, 2019	Novan Secures Up to $35 Million in Non-Dilutive Funding
March 19, 2019	Novan and Sato Advance Japan Market and Dermatology Partnership
March 11, 2019	Novan Completes End-of-Phase 2 Meeting and Provides Additional Business Updates
January 30, 2019	Novan Provides Business Update
January 2, 2019	Novan Announces Management Changes and Provides Business Update